Jiangsu Recbio Technology's (HKG:2179) board approved the proposed conversion of 141,953,490 unlisted shares into H shares, a Wednesday Hong Kong bourse filing said.
Conversion will take place after the company obtains all necessary approvals.
Following completion, the company will have a total of 458,092,179 H shares in issue, making up 94.85% of its total share capital.
The firm will apply to the Hong Kong Stock Exchange to list and deal in the converted H shares.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。